CD8A and neoplasm: Then PD-1 in the nucleus of the T-cells is upregulated by the activation of AHR within CD8+ T-cells, thereby promoting tumor evasion of immune monitoring and tumor progression (Murray et al., 2014; Liu et al., 2018).